Case Study: Global Pharmaceutical Company avoids $1 million in licensing costs with SoftwareONE

Softwareone Helps Global Pharmaceutical Company Avoid Costs Close to $1 Million

Global Pharmaceutical Company, a long-established multinational drug maker, relied on Microsoft software across its U.S. offices but had poor visibility into its licensing position. The company was unsure whether it was properly licensed, risked both under- and over-licensing, and lacked clear information about the software assets and license types it actually needed.

SoftwareONE’s Software Asset Management (SAM) team assessed the Microsoft estate, compared installed software with existing licenses, and helped right-size licensing by moving Microsoft Office users from Professional to Standard and optimizing SQL Server licensing. SoftwareONE enabled the customer to avoid more than $1 million in potential licensing costs, improve compliance, gain full visibility into its software assets, and better align software spend with business needs.